Loading insider details...
Beta
Latest Form 4 (Jan 9, 2026): Grant/Award of 690,900 CERO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jan 9, 2026 | CERO THERAPEUTICS HOLDINGS, INC. (CERO) | Grant/Award | 690,900 | n/a |
| Jun 2, 2025 | CERO THERAPEUTICS HOLDINGS, INC. (CERO) | Grant/Award | 9,326 | n/a |
| Mar 6, 2025 | CERO THERAPEUTICS HOLDINGS, INC. (CERO) | Grant/Award | 17,923 | n/a |
| Feb 26, 2025 | CERO THERAPEUTICS HOLDINGS, INC. (CERO) | Grant/Award | 127,500 | n/a |
| Dec 5, 2024 | CERO THERAPEUTICS HOLDINGS, INC. (CERO) | Grant/Award | 127,500 | n/a |
| May 17, 2024 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/Award | 1,387 | $2.3K |
| Mar 28, 2024 | CERO THERAPEUTICS HOLDINGS, INC. (CERO) | Grant/Award | 112,500 | n/a |
| Feb 21, 2024 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/Award | 40,000 | n/a |
| Nov 16, 2023 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/Award | 4,524 | $2.2K |
| May 16, 2023 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/Award | 4,863 | $2.2K |